CHMP approves Pradaxa for AF/stroke prevention: http://www.reuters.com/article/2011/04/15/boehringer-pradaxa-idUSLDE73E0AO20110415 This is the second indication for Pradaxa in the EU; the first approval, for VTE prevention, came in 2008 (#msg-27956748). In the US, Pradaxa was approved for AF/stroke prevention in 2010 (#msg-55725156), but it has not yet been approved in any other indication.